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THE SEQUENCE OF EVENTS leading to a Ca2 signal during cardiac
excitation-contraction (EC) coupling is well known (3). With
each beat, the propagating action potential depolarizes the
sarcolemma of the excitable myocytes within the heart. Mem-
brane depolarization leads to the activation of voltage-operated
Ca2 channels (VOCs), thereby causing a brief influx of Ca2.
The Ca2 influx is sensed and amplified by Ca2 release
channels known as ryanodine receptors (RyRs), which are
expressed on the sarcoplasmic reticulum (SR) in close appo-
sition to the VOCs. The RyRs are activated by the Ca2
permeating across the VOCs via a process known as Ca2-
induced Ca2 release (CICR).
Although RyRs are the principal Ca2 release channels within
cardiomyocytes, they are not the only route for Ca2 to be
mobilized from intracellular stores. Cardiac myocytes also ex-
press inositol 1,4,5-trisphosphate (InsP3) receptors (InsP3Rs),
albeit at an 100-fold lower level than RyRs. InsP3Rs are
structurally and functionally similar to RyRs. They have the
same tetrameric pinwheel structure and similarly possess car-
boxy-terminal transmembrane helices that form the ion pore
and a large cytoplasmic amino-terminal portion. Although
InsP3Rs absolutely require InsP3 for activation, they can also
be considered as CICR channels, since cytosolic Ca2 has a
bimodal effect on InsP3R open probability similar to the action
it has on RyRs (17).
Three InsP3R isoforms have been identified and cloned.
They are expressed at distinctive ratios in different mammalian
tissues. Studies have shown that the three InsP3R isoforms
have subtly divergent properties (14). It is believed (although
not yet widely demonstrated) that expression of different
InsP3R isoforms can generate distinct Ca2 signals. Within the
heart, it appears that adult atrial and ventricular myocytes
express largely type 2 InsP3Rs (9, 10). The functional conse-
quence of expressing this isoform in myocytes is unclear. Type
2 InsP3Rs have the highest affinity for InsP3, but why this
should relate to myocyte physiology is not known. Type 1 and
type 3 InsP3R isoforms may also be expressed in the heart, in
particular within Purkinje cells (19) and neonatal myocytes (12).
Despite long-standing evidence for the expression of func-
tional InsP3Rs in the heart (20), it is only recently that they
have been convincingly shown to have a significant effect on
the activity of cardiac myocytes. This is essentially due to a
flurry of publications that have explored the involvement of
InsP3Rs in regulating cardiac EC coupling, development, pace-
making, and gene transcription. A study by Lothar Blatter and
colleagues in the American Journal of Physiology-Heart and
Circulatory Physiology (5a) provides yet more compelling
evidence for InsP3Rs being modulators of cardiomyocyte sig-
naling.
The central message of the study by Domeier et al. (5a) is
that InsP3R activation underlies the positive inotropic action of
endothelin-1 (ET-1) on ventricular myocytes. ET-1 is a potent
vasoconstrictor hormone that has been shown to have inotro-
pic, arrhythmic, and hypertrophic effects on cardiomyocytes.
Domeier et al. present molecular evidence for InsP3R expres-
sion in their rabbit ventricular myocytes and demonstrate that
ET-1 provokes increases in cellular InsP3 concentration. Given
these two pieces of evidence, it is inevitable that InsP3R-
evoked Ca2 signals will occur. However, the critical question
is, in what way can the relatively few InsP3Rs influence cardiac
Ca2 signaling?
The most obvious effect of InsP3Rs would be to contribute
to systolic Ca2 increases. Because of their ability to act as
CICR channels, InsP3Rs could tune into to the regular activa-
tion of VOCs and boost the systolic Ca2 signal. In agreement
with this notion, Domeier et al. found that application of ET-1
to electrically paced rabbit ventricular myocytes caused a
significant increase in the amplitude of systolic Ca2 tran-
sients. Using a pharmacological inhibitor of InsP3R activation
and adenovirus-mediated infection of cells with an “InsP3
affinity trap” (essentially a high-affinity mutant of the InsP3R
ligand binding domain), they demonstrated that the InsP3R
activity was responsible for all of the ET-1-stimulated increase
in systolic Ca2 signals. Given that receptors for ET-1 can
couple to several G proteins (e.g., Gq/11, G12/13, Gi) that can
putatively activate a host of downstream processes, it is per-
haps a little surprising that all of the inotropic effect of ET-1 is
due to InsP3. However, the data of Domeier et al. pinpoint the
significance of InsP3Rs in the context of hormonal stimulation
of the heart.
Despite this convincing demonstration for a role of InsP3Rs
in modulating cardiac Ca2 signaling, there are still more
questions than answers with regard to the role of these channels
in the heart. For example, there are unexplained differences in
the effect of InsP3R activation in the ventricular myocytes from
different mammalian species. In the case of rat ventricular
cardiomyocytes, the predominant effect of InsP3R activation
appears to be the generation of proarrhythmic Ca2 transients,
with only a modest inotropic effect (16), whereas in the study
by Domeier et al. (5a) using rabbit ventricular myocytes
InsP3R activation caused inotropy but not arrhythmias. In
contrast, with cat ventricular myocytes InsP3R activation does
not generate inotropy or arrhythmias. Domeier et al. comment
on these interesting species differences and suggest that the
functional effect of InsP3Rs may depend on the degree to
which SR Ca2 release contributes to systolic Ca2 transients.
They argue that species in which SR Ca2 release is a major
component of the systolic Ca2 signal during EC coupling
(substantial in rat and less so in cat) will be most profoundly
affected by the participation of InsP3Rs.
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Although the effects of InsP3Rs may be variable in mam-
malian ventricular myocytes, there is much more consistency
in the response of atrial cells across species. For example,
substantial InsP3-mediated responses have been demonstrated
in atrial myocytes from mouse (9), rat (4), and cat (25). For an
unknown reason, atrial myocytes express more InsP3Rs than
their ventricular counterparts (10). This probably explains why
InsP3R-evoked changes in Ca2 signaling are much easier to
observe in atrial cells. This is also true for neonatal myocytes
(12) and Purkinje cells (19), which similarly have substantial
InsP3R expression. In fact, it is an interesting correlation that
cardiac cells without t-tubules (i.e., not ventricular myocytes)
appear to express the most InsP3Rs. Given that nontubulated
cells rely on the centripetal propagation of Ca2 waves for EC
coupling (5), InsP3Rs could play a critical role alongside the
RyRs in boosting systolic Ca2 transients.
In general, stimulation of cardiac myocytes with an InsP3-
generating agonist, such as ET-1, provokes inotropy and ar-
rhythmias. However, with both adult atrial and ventricular
myocytes the degree of inotropy caused by InsP3R activation is
generally modest compared with their substantial proarrhyth-
mic effect. Indeed, the activation of InsP3Rs in cardiac tissue
has been more commonly linked to the generation of arrhyth-
mias than any other cellular effect. This begs the question of
whether the InsP3Rs are more likely to have a pathological role
in the adult heart. However, it would seem strange that the
heart would express Ca2 channels that allow modest positive
changes in EC coupling while generating substantial arrhyth-
mic activity. Perhaps InsP3Rs have other, more significant,
cardiac functions that are distinct from modulating EC cou-
pling?
One such putative role of cardiac InsP3Rs could be to
generate Ca2 signals that are completely dissociated from EC
coupling. Indeed, it appears that InsP3Rs are strategically
located within cardiomyocytes for this purpose. Several studies
have pinpointed the location of InsP3Rs within or around the
nucleus (1, 12, 21). Furthermore, it is apparent that direct
activation of InsP3Rs in permeabilized myocytes, or stimula-
tion of intact cells with InsP3-generating stimuli, can give rise
to nucleus-specific Ca2 signals, and that the nuclear envelope
is an InsP3-releasable Ca2 store (4, 8, 12, 21, 24). Relative to
the cytosolic compartment (which has abundant Ca2-ATPases
and mitochondria), nucleoplasm has a poor Ca2 sequestration
capacity. This means that Ca2 signals typically persist longer
within nuclei. Indeed, a transient perinuclear Ca2 release
event is likely to barely impact on the cytosol because of
sequestration, whereas it can penetrate into the nucleus and
persist much longer (11). It has been shown that opening of
peri- or intranuclear InsP3Rs is sufficient to activate Ca2-
sensitive gene reporters in myocytes (21), indicating that
InsP3-dependent nucleus-specific Ca2 signals are capable of
driving cardiac gene transcription. The autonomous activation
of nuclear InsP3Rs may provide a mechanism for dissociating
the Ca2 signals underlying gene transcription from the bulk
Ca2 changes that occur during EC coupling (15).
A further function for InsP3Rs, for which there have also
been several recent reports, is to generate Ca2 signals in the
developing heart (7, 13, 18). Because of their ability to act as
autonomous CICR channels, InsP3Rs can generate repetitive
Ca2 oscillations. This is well described for nonexcitable cell
types, which largely rely on InsP3Rs for Ca2 mobilization (2).
Similar periodic InsP3R activity appears to underlie the initi-
ation of pacemaking and differentiation of embryonic cardiac
myocytes. The dependence of cardiac myocytes on InsP3Rs
evidently changes with development. They are very obviously
present in embryonic myocytes, and are still abundant in
neonates even though EC coupling has switched to VOCs/
RyRs (12), but their expression rapidly diminishes in the
postnatal period. This developmental loss of InsP3R expression
is reversed under some pathological conditions, such as heart
failure (6), mitral valve disease (22), and atrial fibrillation (23).
It is now beyond doubt that cardiac myocytes express
functional InsP3Rs, and that these channels are present from
embryo to adult. However, their cellular roles are still rather
enigmatic. They have been linked to inotropy, chronotropy,
arrhythmias, pacemaking, and gene transcription. That a rela-
tively small population of Ca2 release channels can impact on
so many different processes is very intriguing given that
myocytes see regular subsecond Ca2 signals via EC coupling.
Either the modulation of EC coupling by InsP3Rs or the
strategic location of InsP3Rs allows them to have a dispropor-
tionately large effect.
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